Evaluation of tricuspid valve regurgitation following laser lead extraction†
Autor: | Julia Vogler, Liesa Castro, Stephan Willems, Samer Hakmi, Simon Pecha, Nils Gosau, Hermann Reichenspurner, M. Linder |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
Pulmonary and Respiratory Medicine Pacemaker Artificial medicine.medical_specialty Regurgitation (circulation) 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Tricuspid Valve Insufficiency Internal medicine Tricuspid valve endocarditis medicine Humans 030212 general & internal medicine Lead (electronics) Device Removal Aged Retrospective Studies Aged 80 and over Tricuspid valve Ejection fraction business.industry General Medicine Middle Aged Defibrillators Implantable medicine.anatomical_structure Cardiology Female Surgery Laser Therapy Tricuspid Valve Regurgitation Cardiology and Cardiovascular Medicine business Echocardiography Transesophageal Lead extraction |
Zdroj: | European Journal of Cardio-Thoracic Surgery. 51:1108-1111 |
ISSN: | 1873-734X 1010-7940 |
Popis: | Objectives The objective of this study was to examine the effect of laser lead extraction (LLE) on the development of post-procedural tricuspid regurgitation (TR). Some reports have suggested an increase in TR associated with LLE. We present a series of patients who underwent both, LLE and complete echocardiographic evaluation for TR. Methods A single centre analysis of consecutive patients referred for LLE between January 2012 and August 2015. One hundred and three patients had tricuspid valve function evaluated before the procedure with a transthoracic echocardiography (TTE), during the procedure using transoesophageal echocardiography and postoperatively using a TTE. TR was graded from 0 (none) to 4 (severe). Results We treated 235 leads in 103 patients, including 118 ventricular leads. Seventy-seven were male (74.8%) and 26 female (25.2%), with a mean age of 65.6 ± 15.4 years. Mean time from initial lead implantation was 98.0 ± 67.3 months. Twenty-one patients (20.4%) had ejection fraction below 30%. No intra-procedural worsening of tricuspid valve function was seen with TEE in any of the patients. Ten patients (9.7%) were found to have TR before LLE that returned to normal valve function after the procedure. Two patients (1.9%) experienced mild TR after the procedure (both with tricuspid valve endocarditis). Ninety-one patients (88.3%) did not experience any significant change of the tricuspid valve function after LLE. Conclusion Transthoracic and transoesophageal echocardiography findings showed that laser lead extraction was not associated with a significant increase in the incidence of tricuspid valve regurgitation. |
Databáze: | OpenAIRE |
Externí odkaz: |